Zdrowie i gospodarka · 17/11/2014
FDA Announces Draft Guidance for Rare Pediatric Disease Priority Review Vouchers
The FDA is releasing a draft guidance outlining the criteria for awarding priority review vouchers to sponsors of rare pediatric disease product applications, aiming to encourage development of new treatments for rare pediatric diseases.
Source: Federal Register — Food and Drug AdministrationOpen original release →